Literature DB >> 20382843

Systematic cytokine receptor profiling reveals GM-CSF as a novel TLR-independent activator of human plasmacytoid predendritic cells.

Cristina Ghirelli1, Raphaël Zollinger, Vassili Soumelis.   

Abstract

Human plasmacytoid predendritic cells (pDCs) can be activated during microbial infection through Toll-like receptor engagement. They are also involved in nonmicrobial inflammatory diseases, but their activation pathways in this context remain elusive. To identify Toll-like receptor-independent pDC activators, we performed a systematic analysis of cytokine receptors on primary human pDCs. Six receptors were expressed both at mRNA and protein levels: interleukin-3 receptor (IL-3R), IL-6R, IL-10R, IL-18R, interferon-gamma receptor, and granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor. Only GM-CSF and IL-3 were able to efficiently promote pDC survival and induce their differentiation into dendritic cells. Allogeneic naive CD4 T cells primed with GM-CSF-activated pDCs produced more interferon-gamma and less IL-4 and IL-10 compared with IL-3-activated pDCs, indicating a shift in the Th1/Th2 balance. Our data point at a novel function of GM-CSF, which may serve as a link between a pathologic inflammatory environment, pDC activation, and the modulation of CD4 T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382843     DOI: 10.1182/blood-2010-01-266932

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  A chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responses.

Authors:  Thijs van Montfort; Mark Melchers; Gözde Isik; Sergey Menis; Po-Ssu Huang; Katie Matthews; Elizabeth Michael; Ben Berkhout; William R Schief; John P Moore; Rogier W Sanders
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization.

Authors:  Didier Meseure; Kinan Drak Alsibai; Andre Nicolas
Journal:  Cancer Microenviron       Date:  2014-12-19

Review 3.  Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases.

Authors:  John A Hamilton; Andrew D Cook; Paul P Tak
Journal:  Nat Rev Drug Discov       Date:  2016-12-29       Impact factor: 84.694

4.  T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26.

Authors:  Stephan Meller; Jeremy Di Domizio; Kui S Voo; Heike C Friedrich; Georgios Chamilos; Dipyaman Ganguly; Curdin Conrad; Josh Gregorio; Didier Le Roy; Thierry Roger; John E Ladbury; Bernhard Homey; Stanley Watowich; Robert L Modlin; Dimitrios P Kontoyiannis; Yong-Jun Liu; Stefan T Arold; Michel Gilliet
Journal:  Nat Immunol       Date:  2015-07-13       Impact factor: 25.606

Review 5.  GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.

Authors:  Anil Kumar; Adeleh Taghi Khani; Ashly Sanchez Ortiz; Srividya Swaminathan
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

6.  Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age.

Authors:  Archana Kulkarni-Munje; Nandini Malshe; Sonali Palkar; Aniket Amlekar; Sanjay Lalwani; Akhilesh Chandra Mishra; Vidya Arankalle
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 7.  Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions.

Authors:  Philippe Saas; Alexis Varin; Sylvain Perruche; Adam Ceroi
Journal:  F1000Res       Date:  2017-04-10

8.  Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses.

Authors:  Xiaoming Zhang; Alice Lepelley; Elie Azria; Pierre Lebon; Gwenaelle Roguet; Olivier Schwartz; Odile Launay; Claude Leclerc; Richard Lo-Man
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

9.  Chimeric HIV-1 envelope glycoproteins with potent intrinsic granulocyte-macrophage colony-stimulating factor (GM-CSF) activity.

Authors:  Gözde Isik; Thijs van Montfort; Maikel Boot; Viviana Cobos Jiménez; Neeltje A Kootstra; Rogier W Sanders
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis.

Authors:  Suzanne Kafaja; Isela Valera; Anagha A Divekar; Rajan Saggar; Fereidoun Abtin; Daniel E Furst; Dinesh Khanna; Ram Raj Singh
Journal:  JCI Insight       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.